• Mashup Score: 0

    Professor Awen Gallimore’s research has led to new clinical trials that test a new treatment option to stop bowel cancer coming back after surgery.

    Tweet Tweets with this article
    • Research led by our Associate Editor Prof Awen Gallimore @CUSystemsImmu 🙌 This @WorldwideCancer article follows how @GallimoreGodkin findings in regulatory #Tcells have now sparked clinical trials for a new #bowelcancer drug 👉https://t.co/Zc8VBZI2Rc #ThankYouImmunology 🎉 https://t.co/wBRgT9Lvgp